Laurence H. Baker

23.2k total citations · 3 hit papers
247 papers, 11.9k citations indexed

About

Laurence H. Baker is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Laurence H. Baker has authored 247 papers receiving a total of 11.9k indexed citations (citations by other indexed papers that have themselves been cited), including 116 papers in Pulmonary and Respiratory Medicine, 97 papers in Oncology and 46 papers in Surgery. Recurrent topics in Laurence H. Baker's work include Sarcoma Diagnosis and Treatment (83 papers), Cancer therapeutics and mechanisms (24 papers) and Lymphoma Diagnosis and Treatment (20 papers). Laurence H. Baker is often cited by papers focused on Sarcoma Diagnosis and Treatment (83 papers), Cancer therapeutics and mechanisms (24 papers) and Lymphoma Diagnosis and Treatment (20 papers). Laurence H. Baker collaborates with scholars based in United States, United Kingdom and France. Laurence H. Baker's co-authors include Scott M. Schuetze, Robert S. Benjamin, Robert G. Maki, Vainutis K. Vaitkevicius, Rashmi Chugh, Mark M. Zalupski, Dafydd G. Thomas, Ned L. Cooney, V. K. Vaitkevicius and J. Sybil Biermann and has published in prestigious journals such as The Lancet, JAMA and Journal of Clinical Oncology.

In The Last Decade

Laurence H. Baker

245 papers receiving 11.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Phase III Randomized, Intergroup Trial Assessing Imatinib Mesylate At Two Dose Levels in Patients With Unresectable or Metastatic Gastrointestinal Stromal Tumors Expressing the Kit Receptor Tyrosine Kinase: S0033

2008 768 citations Robert S. Benjamin, Laurence H. Baker et al. Journal of Clinical Oncology profile →
Randomized Phase II Study of Gemcitabine and Docetaxel Compared With Gemcitabine Alone in Patients With Metastatic Soft Tissue Sarcomas: Results of Sarcoma Alliance for Research Through Collaboration Study 002

2007 531 citations Robert G. Maki, J. Kyle Wathen et al. Journal of Clinical Oncology profile →
Efficacy and Safety of Trabectedin in Patients With Advanced or Metastatic Liposarcoma or Leiomyosarcoma After Failure of Prior Anthracyclines and Ifosfamide: Results of a Randomized Phase II Study of Two Different Schedules

2009 397 citations Sant P. Chawla, Laurence H. Baker et al. Journal of Clinical Oncology profile →

Peers

Countries citing papers authored by Laurence H. Baker

Since Specialization

Citations

This map shows the geographic impact of Laurence H. Baker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laurence H. Baker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laurence H. Baker more than expected).

Fields of papers citing papers by Laurence H. Baker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laurence H. Baker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laurence H. Baker. The network helps show where Laurence H. Baker may publish in the future.

Co-authorship network of co-authors of Laurence H. Baker

This figure shows the co-authorship network connecting the top 25 collaborators of Laurence H. Baker. A scholar is included among the top collaborators of Laurence H. Baker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laurence H. Baker. Laurence H. Baker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The effects of feed restriction, time of day, and time since feeding on behavioral and physiological indicators of hunger in broiler breeder hens 2022 ·Poultry Science ·Laura Dixon, Ian Dunn, Sarah Brocklehurst, Laurence H. Baker, Tim Boswell, (unknown), (unknown), Victoria Sandilands, Peter W.F. Wilson, Richard B. D’Eath	16
2	Can a quantitative assessment of SARS-CoV-2 PCR predict degree of severity and outcomes in critical care patients with COVID-19? 2021 ·Infezioni in Medicina ·(unknown), (unknown), (unknown), Laurence H. Baker, (unknown), (unknown), Buddhini Samaraweera, Adhyana I. K. Mahanama, Emanuela Pelosi, Eleri Wilson-Davies, Ahilanandan Dushianthan, Kordo Saeed	1
3	The Bromodomain BET Inhibitor JQ1 Suppresses Tumor Angiogenesis in Models of Childhood Sarcoma 2016 ·Molecular Cancer Therapeutics ·Hemant K. Bid, Doris A. Phelps, (unknown), Denis C. Guttridge, Jiayuh Lin, Cheryl A. London, Laurence H. Baker, Xiaokui Mo, Peter J. Houghton	66
4	Pharmacologic Inhibition of MEK Signaling Prevents Growth of Canine Hemangiosarcoma 2013 ·Molecular Cancer Therapeutics ·(unknown), Brian J. Nickoloff, Karl Dykema, Elissa A. Boguslawski, (unknown), (unknown), (unknown), Laurence H. Baker, Dafydd G. Thomas, Debra A. Kamstock, Barbara E. Kitchell, Kyle A. Furge, Nicholas S. Duesbery	21
5	Epidemiology of Helicobacter pylori infection in six Latin American countries (SWOG Trial S0701) 2012 ·Cancer Causes & Control ·Carolina Porras, Jesse Nodora, Rachael Sexton, Catterina Ferreccio, Silvia Jiménez, Ricardo L. Domínguez, Paz Cook, Garnet L. Anderson, Douglas R. Morgan, Laurence H. Baker, E. Robert Greenberg, Rolando Herrero	111
6	R1507, a Monoclonal Antibody to the Insulin-Like Growth Factor 1 Receptor, in Patients With Recurrent or Refractory Ewing Sarcoma Family of Tumors: Results of a Phase II Sarcoma Alliance for Research Through Collaboration Study 2011 ·Journal of Clinical Oncology ·Alberto S. Pappo, Shreyaskumar Patel, John Crowley, Denise K. Reinke, Klaus-Peter Kuenkele, Sant P. Chawla, Guy C. Toner, Robert G. Maki, Paul A. Meyers, Rashmi Chugh, Kristen N. Ganjoo, Scott M. Schuetze, Heribert Juergens, Michael Leahy, Birgit Geoerger, Robert S. Benjamin, Lee J. Helman, Laurence H. Baker	252
7	The reaction of brown and white strains of hens to enriched cages. 2009 ·Victoria Sandilands, Laurence H. Baker, Sarah Brocklehurst	3
8	Histologic Alterations from Neoadjuvant Chemotherapy in High-Grade Extremity Soft Tissue Sarcoma: Clinicopathological Correlation 2008 ·The Oncologist ·David R. Lucas, Malti Kshirsagar, J. Sybil Biermann, Merlın Hamre, Dafydd G. Thomas, Scott M. Schuetze, Laurence H. Baker	52
9	Randomized Phase II Study of Gemcitabine and Docetaxel Compared With Gemcitabine Alone in Patients With Metastatic Soft Tissue Sarcomas: Results of Sarcoma Alliance for Research Through Collaboration Study 002 breakdown → 2007 ·Journal of Clinical Oncology ·Robert G. Maki, J. Kyle Wathen, Shreyaskumar Patel, Dennis A. Priebat, Scott H. Okuno, Brian L. Samuels, Michael Fanucchi, David C. Harmon, Scott M. Schuetze, Denise K. Reinke, Peter F. Thall, Robert S. Benjamin, Laurence H. Baker, Martee L. Hensley	531
10	Examining techniques for humane culling: chickens' aversion to various gases. 2006 ·Victoria Sandilands, (unknown), Laurence H. Baker, N.H.C. Sparks	1
11	Essential erbB family phosphorylation in osteosarcoma as a target for CI‐1033 inhibition 2005 ·Pediatric Blood & Cancer ·Dennis P.M. Hughes, Dafydd G. Thomas, Thomas J. Giordano, Kevin T. McDonagh, Laurence H. Baker	43
12	Absence of HER2/neu gene expression in osteosarcoma and skeletal Ewing's sarcoma. 2002 ·PubMed ·Dafydd G. Thomas, Thomas J. Giordano, Donita Sanders, J. Sybil Biermann, Laurence H. Baker	77
13	A southwest oncology group and cancer and leukemia group B phase II study of doxorubicin, dacarbazine, ifosfamide, and mesna in Adults with advanced osteosarcoma, ewing's sarcoma, and rhabdomyosarcoma 1998 ·Cancer ·(unknown), John Crowley, Stanley P. Balcerzak, Raymond A. Kempf, Raymond B. Weiss, Gerald H. Clamon, Laurence H. Baker	20
14	A southwest oncology group and cancer and leukemia group B phase II study of doxorubicin, dacarbazine, ifosfamide, and mesna in Adults with advanced osteosarcoma, ewing's sarcoma, and rhabdomyosarcoma 1998 ·Cancer ·Karen H. Antman, John Crowley, Stanley P. Balcerzak, Raymond A. Kempf, Raymond B. Weiss, Gerald H. Clamon, Laurence H. Baker	3
15	A Southwest Oncology Group and Cancer and Leukemia Group B phase II study of doxorubicin, dacarbazine, ifosfamide, and mesna in adults with advanced osteosarcoma, Ewing's sarcoma, and rhabdomyosarcoma. 1998 ·PubMed ·Karen H. Antman, John Crowley, S P Balcerzak, Raymond A. Kempf, R B Weiss, Gerald H. Clamon, Laurence H. Baker	25
16	Anticancer drug discovery and development : natural products and new molecular models : proceedings of the Second Drug Discovery and Development Symposium, Traverse City, Michigan, USA, June 27-29, 1991 1994 ·Kluwer Academic Publishers eBooks ·Frederick A. Valeriote, Thomas H. Corbett, Laurence H. Baker	1
17	Combination chemotherapy in the management of disseminated soft tissue sarcomas - A southwest oncology group (SWOG) study 1979 ·Proceedings of the American Association for Cancer Research ·Laurence H. Baker, Robert S. Benjamin, G Fine	6
18	Chemotherapy for metastatic osteosarcoma: studies by the M.D. Anderson Hospital and the Southwest Oncology Group 1978 ·Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) ·Robert S. Benjamin, Laurence H. Baker, Robert M. OʼBryan	5
19	Phase 1-11 study of DTIC and cyclocytidine in disseminated malignant melanoma. 1976 ·Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) ·Michael K. Samson, Laurence H. Baker, (unknown), V. Ratanatharathorn	2
20	Role of DTIC (NSC-45388) in the chemotherapy of sarcomas. 1976 ·Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) ·Jeffrey A. Gottlieb, Robert S. Benjamin, Laurence H. Baker, Robert M. OʼBryan, J. G. Sinkovics, Barth Hoogstraten, Joseph M. Quagliana, Saul E. Rivkin, G. P. Bodey, V. Rodriguez, G. R. Blumenschein, John H. Saiki, Charles A. Coltman, M. A. Burgess, Patricia Sullivan, Tate Thigpen, R Bottomley, S P Balcerzak, Thomas E. Moon	114

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact